Yu‐Ting Xue

机构：Fujian Medical University, First Affiliated Hospital of Fujian Medical University

发表论文 25 篇 · 总被引 209 次 · h-index 9

代表论文

• Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma (2023 · Biomarker Research · 被引 43)
• Mechanical signal modulates prostate cancer immune escape by USP8-mediated ubiquitination-dependent degradation of PD-L1 and MHC-1 (2025 · Cell Death and Disease · 被引 20)
• Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study (2022 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 18)
• Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1 (2024 · Oncogene · 被引 17)
• A novel CD8+ T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer (2023 · Inflammation Research · 被引 16)
• A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients (2023 · International Journal of Molecular Sciences · 被引 16)